Skip to content
Subscriber Only

Carlyle Sees India M&A Accelerating on Pharma, Technology Deals

  • Co-head of Asia buyouts sees substantial growth in 5-7 years
  • Private equity firm to focus on digital, media, health care
Indians Shopping Only for Essentials Despite Economy Reopening
Photographer: Prashanth Vishwanathan/Bloomberg

Dealmakers in India will be busier than ever as global investors are going to follow Facebook Inc. and Google in deploying capital into the country, according to Carlyle Group.

The South Asian nation has become Carlyle’s No. 2 investment destination in Asia after China, according to Gregory M. Zeluck, its Hong Kong-based managing director and co-head for buyout funds in the region. The U.S. firm has announced two deals in India in the past month -- an acquisition of a 20% stake in billionaire Ajay Piramal’s pharmaceutical business for $490 million and paying $235 million for a stake in Bharti Airtel Ltd.’s data-center business.